TrialThe British journal of dermatology2021

A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial.

C Abels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.